The company has generated evidence that shows its system is better than experts at assessing vessel narrowing, plaque volume ...

Cleerly aims to use its AI-driven plaque detection technology to develop a new standard of care for heart disease.

The investment is the second in as many weeks for Morgan Health, which co-led $80 million round in autism-focused startup, ...

Cleerly has claimed an additional $106 million in funding to boost the reach of its artificial intelligence programs for ...

Although heart disease is the leading cause of death in the United States, a significant portion of people who experience ...